Braxia Scientific Corp.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a BRAXF research report →
Price Chart
About the company
Braxia Scientific Corp. functions as a medical research entity that also runs clinics, offering ketamine therapies to individuals suffering from depression and linked conditions. Beyond its clinical services, the company is actively engaged in discovering and bringing to market novel pharmaceutical compounds and innovative delivery methods.
- CEO
- Peter Rizakos
- IPO
- 2020
- Employees
- 5
- HQ
- Toronto, ON, CA
Get TickerSpark's AI analysis on BRAXF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $28.33K
- P/E
- -0.09
- PEG
- -0.00
- P/S
- 0.75
- P/B
- 0.71
- EV/EBITDA
- -0.01
- Div Yield
- 0.00%
- Gross Margin
- 9.12%
- Op Margin
- -397.00%
- Net Margin
- -697.48%
- ROE
- -248.72%
- ROIC
- -408.30%
Latest fiscal year · YoY change
- Revenue
- $1.88M+26.7%
- Gross Profit
- $171.74K+105.2%
- Op Income
- $-7,480,135
- Net Income
- $-13,141,704-8.3%
- EPS
- $-0.06+16.9%
- OCF Growth
- -63.8%
- FCF Growth
- -82.7%
- 52W High
- $0.00
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- 1.45
- RSI (14)
- 54
- Avg Volume
- 394.57K
No earnings-call transcripts are available for BRAXF yet.
- Free Float
- 94.8%
- Shares Outstanding
- 283.28M
- Float Shares
- 268.64M
of shares held by institutions
1 13F filers
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Gofen & Glossberg LLC | 40.00K | 0 |
Our BRAXF coverage
Recent articles, reports, and earnings notes.
No research on BRAXF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate BRAXF report →Braxia Scientific Update
newsfilecorp.com · Feb 19
Braxia Scientific Announces Change in Directors and CEO
newsfilecorp.com · Nov 18
Braxia Scientific Announces Voting Results from the Annual General and Special Meeting of Shareholders
newsfilecorp.com · Oct 10
Braxia Announces Annual General and Special Meeting
newsfilecorp.com · Sep 10
Braxia Scientific Announces Cease Trade Order
newsfilecorp.com · Aug 5
Braxia Scientific Provides Update on Application for Management Cease Trade Order
newsfilecorp.com · Jul 25
Braxia Scientific Announces Application for a Management Cease Trade Order For Late Filing of Audited Annual Financial Statements
newsfilecorp.com · Jul 15
Braxia Scientific Reports Q3 2024 Financial Results
newsfilecorp.com · Feb 29
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.